Evidence map›Paper›PMID 31844304›Full record

ArticleNature chemical biology2020

Engineering yeast phospholipid metabolism for de novo oleoylethanolamide production.

Yi Liu, Quanli Liu, Anastasia Krivoruchko, Sakda Khoomrung, Jens Nielsen

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Reprogramming Metabolic Flux in Escherichia Coli to Enhance Chondroitin Production.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  4. Review
  5. Elevating Phospholipids ProductionInternational journal of molecular sciences · 2022
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Yi LiuDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Quanli LiuDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Anastasia KrivoruchkoDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Sakda KhoomrungDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Jens NielsenDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden. nielsenj@chalmers.se.ORCID http://orcid.org/0000-0002-9955-6003
Chalmers University of Technology · SENovo Nordisk Foundation · DKSiriraj Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phospholipids, the most abundant membrane lipid components, are crucial in maintaining membrane structures and homeostasis for biofunctions. As a structurally diverse and tightly regulated system involved in multiple organelles, phospholipid metabolism is complicated to manipulate. Thus, repurposing phospholipids for lipid-derived chemical production remains unexplored. Herein, we develop a Saccharomyces cerevisiae platform for de novo production of oleoylethanolamide, a phospholipid derivative with promising pharmacological applications in ameliorating lipid dysfunction and neurobehavioral symptoms. Through deregulation of phospholipid metabolism, screening of biosynthetic enzymes, engineering of subcellular trafficking and process optimization, we could produce oleoylethanolamide at a titer of 8,115.7 µg l

Indexed as

Acyl Coenzyme ACDPdiacylglycerol-Serine O-PhosphatidyltransferaseCoenzyme A LigasesEndocannabinoidsEnzymesEscherichia coli ProteinsGene Expression Regulation, FungalGlucoseLysophospholipaseMetabolic EngineeringMicroorganisms, Genetically-ModifiedMonoacylglycerol LipasesOleic AcidsPeriplasmic ProteinsPhospholipidsSaccharomyces cerevisiaeAcyl Coenzyme ACDPdiacylglycerol-Serine O-PhosphatidyltransferaseCHO1 protein, S cerevisiaeCoenzyme A LigasesEndocannabinoidsEnzymesEscherichia coli ProteinsFaa1 protein, S cerevisiaeFAA4 protein, S cerevisiaeGlucoseLysophospholipaseMonoacylglycerol LipasesOleic AcidsoleoylethanolamidePeriplasmic ProteinsPhospholipidsSaccharomyces cerevisiae ProteinstesA protein, E coliYju3 protein, S cerevisiae

Identifiers

PMID31844304
OpenAlexW2996429622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.